International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 4 (July-August 2026) Submit your research before last 3 days of August to publish your research paper in the issue of July-August.

Therapeutic Potential of Arogyavardhini Vati in Non-Alcoholic Fatty Liver Disease: An Ayurvedic Perspective and Contemporary Scientific Review

Author(s) Dr. Sakshi Chahar, Dr. Abhishek Upadhyay, Dr. Pravin Shamrao Sawant, Dr. Daleep Kumar, Dr. Neha Khandelwal
Country India
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the most common chronic liver disorders worldwide and is considered the hepatic manifestation of metabolic syndrome. It is characterized by excessive fat accumulation in the liver without significant alcohol consumption and is closely associated with obesity, insulin resistance, diabetes, dyslipidemia, and sedentary lifestyle. Despite its increasing prevalence, specific pharmacological treatment options remain limited.
In Ayurveda, NAFLD can be understood through the concepts of Agnimandya, Ama, Meda Dhatu Dushti, Kapha-Pitta imbalance, and Yakrit Vikara. Arogyavardhini Vati, a classical herbo-mineral formulation, is traditionally indicated for liver disorders, metabolic dysfunction, and digestive impairment. Its ingredients, including Katuki, Guggulu, Triphala, Neem, Chitraka, Shilajit, Loha Bhasma, Tamra Bhasma, and Abhraka Bhasma, possess hepatoprotective, antioxidant, anti-inflammatory, and hypolipidemic properties.
This review aims to evaluate the therapeutic potential of Arogyavardhini Vati in the management of NAFLD by correlating Ayurvedic principles with available scientific evidence. Current studies suggest beneficial effects on liver function and lipid metabolism; however, further well-designed clinical trials are needed to establish its efficacy and safety.
Keywords Arogyavardhini Vati, Non-Alcoholic Fatty Liver Disease, NAFLD, Ayurveda, Hepatoprotective Activity, Fatty Liver, Metabolic Disorders.
Field Medical / Pharmacy
Published In Volume 8, Issue 4, July-August 2026
Published On 2026-07-05

Share this